Tag Archives: FDA

Prescription by Advertisement: Comparing U.S. and U.K. Controls on Weight-Loss Drug Marketing

By: Emmanuela Yiannikakis In the span of only a few years, GLP-1 weight-loss drugs such as Wegovy, Ozempic, and Mounjaro have become household names. Originally designed for diabetes, these drugs have redefined the global conversation around obesity treatment and, in the process, sparked an unprecedented surge in demand. According to a 2025 review, this surge […]

Innovation and the Increase in Food Recalls in Europe and the United States

By: Samantha Whitsel In the last week of October, Big Macs, taco kits, frozen waffles, and pre-made chicken are all products subject to food recalls across the United States. 2024 is predicted to be a record-breaking year for food recalls in the United States. Europe is facing a similar dilemma, the European Union has said […]

Toxic Beauty: The Disparity in the Regulation of Harmful Chemicals in Cosmetics in the U.S. vs. the E.U.

By: Isabelle Nozari November 11, 2022 When we buy personal care products to use in our daily routines, be it caring for our skin, hair, nails, or applying makeup, we assume that the products marketed for such usage are safe. Unfortunately, however, many recent reports have demonstrated that we may be unknowingly exposing ourselves to […]